Eikon Therapeutics
About Eikon Therapeutics
Eikon Therapeutics is a biotechnology company focused on developing innovative therapies using its proprietary technology platform to target and modulate protein interactions. The company aims to address significant unmet medical needs in various therapeutic areas, including oncology and neurodegenerative diseases.
Business Information
Target Customers
Industry Categories
Business Model
Funding Timeline
| Round | Date | Amount | Investors |
|---|---|---|---|
| Series D | May 22, 2025 | $350.0M | Unknown |
Founders
No founder information available.
Investors
No investor information available.
Recent Mentions
Only three months after banking an eye-popping $350 million series D round, Eikon Therapeutics is citing government funding cuts as the reason behind a 15% workforce reduction. https://t.co/uM3q8cvrFZ
Only three months after banking an eye-popping $350 million series D round, Eikon Therapeutics is citing government funding cuts as the reason behind a 15% workforce reduction! #biotech #VentureCapital #layoff https://t.co/9gjZK1gpcp https://t.co/sIETLGJRit
Similar Startups
BioTroy Therapeutics
87% matchBioTroy Therapeutics is a biotechnology company focused on developing innovative anti-tumor therapeu...
Illimis Therapeutics
86% matchIllimis Therapeutics is a biotechnology company focused on developing innovative therapies to addres...
Tcelltech
86% matchTcelltech is a clinical-stage biopharma focused on developing immunotherapies.
Immunocore
86% matchImmunocore is a leading biotechnology company focused on developing innovative therapies for cancer ...